Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hilkert Rodriguez

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|May 29, 2020
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematuritySarah Hilkert Rodriguez, Sidney A Schechet, Michael J Shapiro, et al.
International Journal of Molecular Sciences|May 27, 2023
Biomarkers of Pediatric Cataracts: A Proteomics Analysis of Aqueous FluidChristos N Theophanous, Donald J Wolfgeher, Asim V Farooq, et al.
Ophthalmology|September 24, 2018
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226)Michael P Blair, Sarah Hilkert Rodriguez, R V Paul Chan, et al.
Journal of Pediatric Ophthalmology and Strabismus|August 14, 2024
Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic HypertensionMizna Akbar, Ema Avdagic, Christine Carlos, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 25, 2020
The early gut microbiome could protect against severe retinopathy of prematurityDimitra Skondra, Sarah Hilkert Rodriguez, Anukriti Sharma, et al.
Frontiers in Pediatrics|July 26, 2023
Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysisEdward F Xie, Sarah Hilkert Rodriguez, Bingqing Xie, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|May 24, 2025
Area deprivation index predicts follow-up in retinopathy of prematurityRebecca E Tanenbaum, Nikita Mokhashi, Alexis K Warren, et al.
Taiwan Journal of Ophthalmology|January 15, 2019
Bevacizumab or laser for aggressive posterior retinopathy of prematurityMichael Blair, Jose Maria Garcia Gonzalez, Laura Snyder, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 15, 2023
Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infantsSarah Hilkert Rodriguez, Michael P Blair, Elise Timtim, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 25, 2019
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROPSarah Hilkert Rodriguez, Colleen Peyton, Katherine Lewis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|May 29, 2020
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematuritySarah Hilkert Rodriguez, Sidney A Schechet, Michael J Shapiro, et al.
International Journal of Molecular Sciences|May 27, 2023
Biomarkers of Pediatric Cataracts: A Proteomics Analysis of Aqueous FluidChristos N Theophanous, Donald J Wolfgeher, Asim V Farooq, et al.
Ophthalmology|September 24, 2018
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226)Michael P Blair, Sarah Hilkert Rodriguez, R V Paul Chan, et al.
Journal of Pediatric Ophthalmology and Strabismus|August 14, 2024
Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic HypertensionMizna Akbar, Ema Avdagic, Christine Carlos, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 25, 2020
The early gut microbiome could protect against severe retinopathy of prematurityDimitra Skondra, Sarah Hilkert Rodriguez, Anukriti Sharma, et al.
Frontiers in Pediatrics|July 26, 2023
Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysisEdward F Xie, Sarah Hilkert Rodriguez, Bingqing Xie, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|May 24, 2025
Area deprivation index predicts follow-up in retinopathy of prematurityRebecca E Tanenbaum, Nikita Mokhashi, Alexis K Warren, et al.
Taiwan Journal of Ophthalmology|January 15, 2019
Bevacizumab or laser for aggressive posterior retinopathy of prematurityMichael Blair, Jose Maria Garcia Gonzalez, Laura Snyder, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 15, 2023
Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infantsSarah Hilkert Rodriguez, Michael P Blair, Elise Timtim, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 25, 2019
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROPSarah Hilkert Rodriguez, Colleen Peyton, Katherine Lewis, et al.
Pageof 3